Project Details
Description
HM2018-32 A Phase 1b Open-Label Study to Evaluate the Safety and Antitumor Activity of Loncastuximab Tesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
Status | Active |
---|---|
Effective start/end date | 11/1/18 → 10/30/22 |
Funding
- ADC THERAPEUTICS SA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.